Lakefront Biotherapeutics | GLPG - Current Assets


Lakefront Biotherapeutics reported EUR2.31B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
argenx SE USD 8.07B 1.17B Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Biogen USD 7.31B 1.88B Jun/2026
Genmab DKK 2.8B 228M Jun/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
GRIFOLS EUR 5.31B 51M Jun/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Incyte USD 6.03B 542.31M Jun/2026
Merck EUR 13.77B 393M Jun/2026
Neurocrine Biosciences USD 1.64B 798.6M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
UCB EUR 6.05B 733M Dec/2025
Vertex Pharmaceuticals USD 12.54B 813.4M Jun/2026